To assess the role of PCK2 in CRC survival we used lentiviral-mediated delivery of shRNAs targeting PCK2 to deplete PCK2 protein (Figure 4A) and performed anchorage-independent growth studies. This evidence concerns the gene PCK2 and colorectal carcinoma.